Product image of Mirtazapina Mylan Generics (Mirtazapine) supplied by GNH India

Mirtazapina Mylan Generics

Active Ingredient:
Mirtazapine
Origin:
EU

Mirtazapina Mylan Generics (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Mylan Generics, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral dosage form for oral use. It treats major depressive disorder in adult patients, improving mood and functional outcomes.

GNH India supplies Mirtazapina Mylan Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mirtazapine is indicated for depressive disorders, acting on noradrenergic and serotonergic pathways.

  • Major depressive disorder: alleviates depressive symptoms and improves overall mood.
  • Depressive episodes with prominent anxiety: reduces anxiety components associated with depression.
  • Depression with insomnia: helps improve sleep quality while treating depressive symptoms.

How It Works

  • Mirtazapine antagonizes central presynaptic α2‑adrenergic receptors, increasing norepinephrine release, and blocks postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic neurotransmission. Additional H1‑receptor antagonism contributes to its sedative properties, collectively producing antidepressant and anxiolytic effects.

Side Effects

Mirtazapine may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Sedation or drowsiness
  • Increased appetite and weight gain
  • Dry mouth
  • Constipation
  • Dizziness or light‑headedness
  • Peripheral edema

Serious or Rare Side Effects

  • Agranulocytosis or severe neutropenia
  • Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome)
  • Suicidal thoughts or behavior, especially early in treatment
  • Serotonin syndrome when combined with other serotonergic agents
  • Hepatotoxicity or abnormal liver function tests

Precautions & Warnings

Before prescribing Mirtazapine, clinicians should consider several safety aspects.

  • Pregnancy: safety not established; use only if potential benefit justifies the risk.
  • Breastfeeding: unknown excretion in milk; weigh maternal benefit against infant risk.
  • Elderly patients: monitor for excessive sedation, orthostatic hypotension, and falls.
  • Concomitant MAO inhibitors: avoid due to risk of hypertensive crisis and serotonin syndrome.
  • Suicidal ideation: closely monitor patients, especially during the initial treatment phase.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Mirtazapine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
  • Other serotonergic agents (SSRIs, SNRIs, tramadol, linezolid): increased risk of serotonin syndrome.
  • Potent CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise mirtazapine plasma levels.

Moderate Interactions (Monitor Closely)

  • CNS depressants (benzodiazepines, alcohol): additive sedation.
  • Anticholinergic drugs: may exacerbate dry mouth and constipation.
  • Antihypertensive agents: potential for enhanced hypotensive effect.

Frequently Asked Questions

Mirtazapina Mylan Generics contains the active ingredient mirtazapine, which is prescribed to treat major depressive disorder in adult patients. It helps alleviate depressive symptoms, improve mood, and can also address associated anxiety and sleep disturbances.

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and by antagonizing postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity. Its additional H1‑receptor antagonism contributes to sedative effects.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for mirtazapine in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, differing from SSRIs and SNRIs by its dual antagonism of α2‑adrenergic and specific serotonin receptors. This profile often results in pronounced sedative and appetite‑stimulating effects, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those concerned about weight gain.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect from moisture and light. Do not refrigerate or freeze the tablets.

Mirtazapina Mylan Generics is taken orally, usually once daily in the evening due to its sedative properties. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include the potential for suicidal thoughts or behaviors, especially at treatment initiation, rare cases of agranulocytosis or severe neutropenia, hypersensitivity reactions such as Stevens‑Johnson syndrome, and serotonin syndrome when combined with other serotonergic agents.

Mirtazapine should be avoided in patients currently taking monoamine oxidase inhibitors, those with known hypersensitivity to the drug, and individuals with severe hepatic impairment without careful monitoring. It is also contraindicated in patients with a history of agranulocytosis related to mirtazapine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mirtazapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT